- Home
- AREN vs VTGN Comparison
AREN vs VTGN Comparison
Compare AREN & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AREN
- VTGN
- Stock Information
- Founded
- AREN 2016
- VTGN 1998
- Country
- AREN United States
- VTGN United States
- Employees
- AREN N/A
- VTGN N/A
- Industry
- AREN Medical/Dental Instruments
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- AREN Health Care
- VTGN Health Care
- Exchange
- AREN Nasdaq
- VTGN Nasdaq
- Market Cap
- AREN 69.8M
- VTGN 72.4M
- IPO Year
- AREN N/A
- VTGN N/A
- Fundamental
- Price
- AREN $1.71
- VTGN $2.41
- Analyst Decision
- AREN
- VTGN
- Analyst Count
- AREN 0
- VTGN 0
- Target Price
- AREN N/A
- VTGN N/A
- AVG Volume (30 Days)
- AREN 216.0K
- VTGN 198.6K
- Earning Date
- AREN 11-14-2024
- VTGN 02-11-2025
- Dividend Yield
- AREN N/A
- VTGN N/A
- EPS Growth
- AREN N/A
- VTGN N/A
- EPS
- AREN N/A
- VTGN N/A
- Revenue
- AREN $234,396,000.00
- VTGN $876,000.00
- Revenue This Year
- AREN $12.73
- VTGN N/A
- Revenue Next Year
- AREN $71.95
- VTGN N/A
- P/E Ratio
- AREN N/A
- VTGN N/A
- Revenue Growth
- AREN 45.45
- VTGN 8.08
- 52 Week Low
- AREN $0.56
- VTGN $2.38
- 52 Week High
- AREN $2.92
- VTGN $5.86
- Technical
- Relative Strength Index (RSI)
- AREN 63.69
- VTGN 32.18
- Support Level
- AREN $1.55
- VTGN $2.38
- Resistance Level
- AREN $1.79
- VTGN $2.53
- Average True Range (ATR)
- AREN 0.16
- VTGN 0.13
- MACD
- AREN -0.02
- VTGN -0.01
- Stochastic Oscillator
- AREN 76.64
- VTGN 0.96
About AREN The Arena Group Holdings Inc.
The Arena Group Holdings Inc is a tech-powered media company that fuses technology, iconic brands, and marketing to deliver vibrant content and experiences that reach million users each month. The company creates robust digital destinations that delight consumers with powerful journalism, news about the things such as favorite sports teams, advice on investing, the inside scoop on personal finance, and the latest on lifestyle essentials. The Company operates in one reportable segment which focuses on a publishing platform. The company generates revenue from Digital and Print, where the majority is generated from Digital. The company owns and operates TheStreet, The Spun, Parade, and Men's Journal and powers more than 320 independent Publisher Partners.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.